Skip to Main Content

Mechanisms of HIV latency

Conditions

HIV/AIDS

Phase COVID-NA

What is the purpose of this trial?

participants will donate 150 ml of blood (around 5 ounces, less than 1/3 of a regular Red Cross blood donation) for each visit. Participants will be compensated. In some occasions, the study participants may be requested to donate for additional times, but no sooner than 8 weeks.

  • Trial with
    University of Massachusetts
  • Start Date
    04/19/2018
  • End Date
    12/31/2048

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000021845REG